Background: Colonic perforation is a rare complication associated with colonoscopy. There are no population-based studies on the risk of colonic perforation in IBD inpatients. Aim: We sought to determine the prevalence of colonic perforation during colonoscopy among IBD inpatients, and to assess its risk factors. Materials and methods: We obtained patient data from the Nationwide Inpatient Sample and used the International Classification of Diseases, the 9th revision, clinical modification codes, to identify IBD patients who had undergone colonoscopy in 2006. The control group consisted of inpatients who had colonoscopy without IBD. Results: Colonic perforation occurred in 344/33,732 (1%) IBD hospitalizations and in 3658/ 578,458 (0.6%) controls without IBD (P = 0.0001). The risk of colonic perforation in the IBD group was significantly higher than the control group even after adjusting for age, gender, comorbidities and endoscopic interventions including endoscopic dilations and colonoscopic polypectomy, with adjusted odds ratio (aOR) of 1.83 (95% confidence interval [CI]: 1.40, 2.38). In addition, older age (aOR = 1.01, 95% CI: 1.006-1.015), female gender (aOR = 1.20; 95% CI: 1.04, 1.38), and therapeutic endoscopic dilation (aOR = 6.63; 95% CI: 3.95, 11.11) were independent risk factors for perforation. Colonoscopic biopsy, polypectomy and the presence of comorbidities did not increase the risk of perforation. Conclusions: There appears to be a higher risk of colonoscopy-associated perforation in IBD inpatients than non-IBD controls. In addition, older age, female patients and endoscopic dilations appeared to be associated with an increased risk for perforation.
Introduction
Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), are chronic, progressive inflammatory conditions. Ileocolonoscopy plays a critical role for diagnosis, differential diagnosis, and treatment. 1, 2 In addition to surveillance colonoscopy in outpatient setting, colonoscopy is a key modality for diagnosis, prediction of prognosis (such as mucosal healing), and in therapy for IBD related strictures. Inpatient colonoscopy in IBD patients is often performed to assess disease activity, disease extent, to identify superimposed infection (such as cytomegalovirus infection and Clostridium difficile infection), and to execute endoscopic therapy (such as stricture dilation). 3 The reported frequency of colonoscopy-associated perforation is highly variable, ranging from 0.03% to 0.3% in the general population. [4] [5] [6] [7] [8] [9] [10] [11] The risk of perforation is 1.9 times higher in colonoscopy with biopsy than that without. 12 Small studies attempting to examine the safety of colonoscopy in general population have also mentioned procedure-related complications in patients with IBD. 13, 14 The safety of therapeutic endoscopy in IBD patients has been evaluated in a meta-analysis in which major complications were reported in 14 (2%) patients. 15 In a recent study, safety of colonoscopy was studied in IBD patients and neither active disease at the time of dilatation nor medical therapy following dilation affected long-term outcomes of endoscopic dilation in CD. 16 To the best of our knowledge, there have been no population-based studies specifically designated to examine the risk of colonoscopy perforation in IBD inpatients. We hypothesized that diagnostic and therapeutic colonoscopy may bear a higher risk for perforation in IBD inpatients. We used the National Inpatient Sample (NIS) database, which is the largest all-payer inpatient care database in the US. We sought to determine the prevalence of colonic perforation among IBD inpatients and to assess its risk factors.
Materials and methods

Data source
The data were obtained from the Nationwide Inpatient Sample (NIS) which has been maintained as a part of Healthcare Cost and Utilization Project (HCUP) by the Agency for Healthcare Research and Quality. This longitudinal hospital care data represent an approximate 20% stratified sample of US community hospitals, including all non-federal short-term general and subspecialty hospitals, public hospitals, and academic medical centers, based on ownership, hospital size, teaching status, US region or rural/ urban locations. Each individual hospitalization is deidentified and maintained in the NIS as a unique entry with 1 primary discharge diagnosis and up to 15 secondary diagnoses during that hospitalization. The data include demographic variables (defined as age, gender, race/ ethnicity, and median income for ZIP code), discharge disposition, primary insurance payers, total hospital charges, and length of stay. For our study we used data from the HCUP NIS for the year 2006, which contain the documented variables from 37 states and 994 hospitals, accounting for over 39 million discharges. The data have been shown to be reliable and concurred with National Hospital Discharge Survey.
Definition of variables
Demographic information was obtained, including age, race, sex, and insurance. Patients with age between 18 and 90 years at admission who underwent colonoscopy were included from the unweighted survey sample. Comorbid conditions were recorded if they were listed among the diagnoses for the hospitalization. To adjust for case-mix, we assessed the burden of comorbid with the Deyo modification of the Charlson Comorbidity Index (CCI). 17 This index has been widely used to measure comorbidity burden from administrative databases. 18 
Study groups, inclusion and exclusion criteria
All eligible patients during the study period were included in the study. The inclusion criteria were inpatients with or without IBD who had colonoscopy. Documentation of inpatient colonoscopy from the database was ascertained using the ICD 9 CM procedure codes 4522, 4523, 4525, 4526, 4527, 4542 and 4543. For the purpose of our primary analysis, we excluded discharges with a secondary diagnosis of colorectal cancer (ICD-9 CM code 1530-1543, 1548). Inpatients with sigmoidoscopy procedures were also excluded from the study.
The eligible patients were divided into two groups. The study group included inpatients who had a diagnosis of IBD who underwent colonoscopy (International Classification of Diseases 9th revision [ICD-9 CM] codes 556.x and 555.x). The control group included hospital discharged patients who underwent colonoscopy, but no listed concomitant diagnosis of IBD (the control group). Thus all patients who were included in the analysis had undergone a colonoscopy during the hospitalization.
We also calculated the number of patients getting colonoscopic interventions including endoscopic polypectomy (ICD-9 CM code 45.42) and stricture dilations (ICD-9 CM code 46.85).
Outcomes
Our primary outcome of interest was prevalence and risk factors of colonoscopic perforation. Perforations were identified using the ICD-9 codes for perforation of intestine and accidental puncture or laceration during a procedure (ICD-9 codes 569.83 and 998.2).
Statistical analysis
All statistical analyses were performed using the survey commands in STATA MP 10.0 (STATA Corp, College Station, TX) to adjust for the complex sampling design of the NIS. Appropriate hospital and discharge level weights were applied to the NIS 2006 data in order to estimate the total number of hospitalizations in the exposed and unexposed cohort and the patients with the outcome of interest. A bivariate analysis was done using the chi squared tests to estimate if the proportion of the outcomes varied by the exposure status. Two-sided p values were reported with a significance level (p) of 0.05. Discharge-level weights published by HCUP were used to produce 95% confidence intervals (CI) for point estimates and to reflect nationwide data during the study period.
Characteristics that were significantly associated with the outcome (p b 0.10) on univariate analysis were included in the final multivariate model. Multivariate logistic regression was used to determine the adjusted odds ratio (OR) of developing a perforation among IBD who underwent colonoscopy after adjusting for the patient characteristics like age, sex and Deyo modification of CCI. Point estimates were represented as adjusted OR with 95% CI. The research protocol was exempted by the institutional review board of the University of Washington, Seattle, WA.
Results
Prevalence of colonic perforation
The study and control groups consisted of 33,732 and 578,458 hospitalizations, respectively. Colonic perforation occurred in 344 (1.0%) in the study group and 3,658 (0.6%) in the control group (p = 0.0001). Table 1 presents the demographic and clinical characteristics between the two groups. Patients with perforation in the IBD group tended to be younger than those in the study group. Patients with perforation in the control group had a greater number of comorbidities than those in the IBD group. A greater number of patients with perforation in the control group had a Charlson index of 3 or more (13%), than that in patients with perforation in the study group (2.9%). More patients with perforation in the IBD group had undergone colonoscopic biopsy, while more patients with perforation in the control group had undergone colonoscopic polypectomy. There was no difference in the rate of colonoscopic dilation performed between the study and control groups.
Comparison of demographic and clinical data
We also compared the risk in patients with UC and CD. The risk of perforation was not significantly different between the patients with the two disease entities. The rate of perforation was 1% and same with both UC and CD (Table 2) .
On univariate analysis, the diagnosis of IBD, older age, female gender and endoscopic dilation were associated with an increased risk for perforation (Table 3) . Comorbidity and race did not influence perforation risk.
Multivariate analysis to identify risk for perforation
The risk of colonic perforation in the IBD group was significantly higher than the control group [adjusted odds ratio (aOR) = 1.83; 95% confidence interval (CI): 1.40, 2.38]. The diagnosis of IBD was an independent risk factor for perforation even after adjusting for age, sex, endoscopic dilation and the presence of comorbidities. On multivariate analysis, older age (aOR = 1.01, 95% CI 1.006-1.015), female gender (aOR = 1.20; 95% CI: 1.04, 1.38) and endoscopic dilation (aOR = 6.63; 95% CI: 3.95, 11.11) were identified as independent risk factors for the risk of perforation in this population group, while colonoscopic biopsy, polypectomy and the presence of other comorbidities did not increase the risk of perforation (Table 4 ).
Discussion
To our knowledge, there were no population-based studies on the safety of colonoscopy in IBD inpatients. This nationwide, population-based study showed that the risk of colonoscopic perforation is increased in IBD inpatients. The diagnosis of IBD by itself was an independent risk factor for perforation, after adjusting for age, gender, endoscopic dilation, and presence of comorbidities. Other independent risk factors for colonoscopic perforation during colonoscopy included older age, female gender and performance of endoscopic dilation. Although these results could not directly be extrapolated to IBD outpatients, they may have impact on clinical management and decision making in IBD patients in general.
Reported risk of perforation in outpatients getting colonoscopy in general population varies from 0.09 to 0.2%. [4] [5] [6] [7] [8] [9] [10] [11] However, the general population could have included a small number of patients with underlying IBD. A few studies on the overall safety of colonoscopy in the general population have specifically mentioned colonoscopy related complications in IBD patients. 13, 14 The presence of non-compliant, thickened and diseased colonic wall and strictures may increase the risk of perforation. In fact, the use of small-caliber endoscopes had been recommended to improve the safety of the procedure in this group of patients. 2 Multiple studies have reported the safety of ileocolonoscopy in IBD patients. In a study of 34 patients with severe UC, no procedure-related complications were reported. 19 Subsequently, in a study of 85 consecutive patients with acute UC, the only complication in one patient was perforation related to colonic dilatation. 20 In a retrospective study of 384 UC patients undergoing surveillance colonoscopies, there was one patient with silent perforation with an underlying stricture. 21 Similarly, a separate study of IBD patients with 151 colonoscopies and 70 polypectomies reported no bleeding or perforation. 22 In a large series of IBD patients of 558 colonoscopies, three perforations were reported, two perforations occurred in patients with CD with strictures and one in a patient with UC. 2 This particular study included 251 inpatients (44.9%) and 307 outpatients (55.1%) and the reported complication rate was 0.7%, which was similar to the finding in our current study with only inpatients being included.
The safety of therapeutic endoscopy was evaluated in a meta-analysis of 13 observational studies involving 347 CD patients. Major complications were reported in 14 cases (2%), including bowel perforation in 13 cases. The authors concluded that endoscopic balloon dilatation was a safe and effective alternative to bowel resection. 15 The results from our study appears to be different from that in the other previous studies on colonoscopy in IBD patients, with the risk for perforation in both diagnostic and therapeutic colonoscopy being higher than that in non-IBD controls. However, all the previous studies suffered from pitfalls from smaller sample size, referral bias, and the lack of controls. In addition, our study only included well-documented hospitalized IBD patients.
The risk of perforation in IBD outpatients as a part of a large study from Medicare database reported the rate as 0.06%. 4 In our study, we found that increasing age was associated with increased risk of perforation in IBD inpatients. Our results support the recent findings from a Medicaid cohort 9 and studies by Levin et al. 12 and Gatto et al. 23 which demonstrated older age was a risk factor for perforation in general population. Thus older patients, with and without IBD are at increased risk for perforation. Possible explanations for the increased risk in IBD patients may be similar to those in non-IBD patients in whom diverticulosis has been shown to be associated with an increased risk of perforation. 24 It could also be attributed to age-associated degenerative changes in the myenteric plexus of the gastrointestinal tract, particularly abnormal appearing ganglia, a decrease in neuron density, and an increase in fibrous components of the neurons. 25, 26 These alterations may result in decreased frequency of colonic contractions, which could alter the elastic properties of the colon, leading to increased vulnerability to the mechanical force from colonoscopy procedure. 24 Colonoscopy is a technically more difficult procedure in some female patients, 27 ,28 which has been ascribed to the greater total colonic length in spite of their smaller stature. Increased colonic length tends to predispose to loop formation and difficulty in passing the colonoscope with consequent patient discomfort during intubation. 27 In addition, females have a more rounded and deeper pelvis which could make them prone to have more loop formation at the sigmoid colon. 27 Therefore, both IBD patients and non-IBD female patients appear to be at increased risk of perforation. The higher complication rate in the IBD population could be also due to multiple factors. Our study utilized the NIS, which included only inpatients. These patients might have been sicker as a group because of their disease activity and colonoscopy in these patients might have led to more perforations as compared to outpatients who were healthier. However in a recently published study, no relationship between the severity of the disease and the complication rate was observed. 2 This study included only 41 patients with severe UC and 59 patients with severe CD and they reported one patient with perforation in the severe CD group. 2 It was interesting that the risk of perforation in non-IBD control group was also higher than previously published studies. Colonoscopy complication rates in asymptomatic or true screening populations were extremely low, with perforation or bleeding ranging from 0% to 0.3%, 4-11 while therapeutic colonoscopy, particularly polypectomy, appears to carry a higher risk with complication rate ranging from 0.7% to 2%. 28 Our control population included hospitalized patients and therapeutic colonoscopies were performed in close to 20% of patients, polypectomy in about 18% of patients and endoscopic dilation was performed in 2.9% of the patients which could explain the perforation rate of 0.6%.
The findings of our study have several clinical implications. The risk factors for perforation following colonoscopy in IBD patients appear to be similar to the general population with older, female patients at higher risk. In general, the frequency of perforation correlates with the endoscopists' experience. 29 Therefore this procedure, in particular therapeutic colonoscopy should preferably be carried out by experienced gastroenterologists or endoscopists. With IBD patients being extensively treated with biologics as well as immunomodulators and corticosteroids, the consequence of perforation may be more detrimental. In addition, the risk of postoperative complications for salvaging surgery may also be increased in patients with infliximab and corticosteroids. 30, 31 Infliximab use was associated with infectious complications, with an odds ratio of 2.7 in a multivariable analysis. 30 In study from our institution, preoperative infliximab use for UC was found to be associated with an increased risk of post-operative infectious complications. 31 Thus, patients with colonoscopy related perforation may land up in ileostomy and may not be able to undergo reconstruction in the immediate post-operative period. IBD patients undergoing colonoscopy get multiple biopsies throughout the colon looking for disease activity as well as for surveillance. Studies have shown the superiority of jumbo forceps as compared to standard forceps in dysplasia surveillance. 32 Although the safety of these forceps has been shown in small studies, their safety and the risk of perforation has not been proven in large studies. Also patients requiring dilation in our study had higher complication rates. Thus the safety of colonoscopy in patients with severe IBD getting surveillance biopsies using the jumbo forceps and IBD patients requiring dilation procedures in the setting of strictures need to be prospectively studied.
There are several limitations in our study which need to be acknowledged before the application of our study results. This is a retrospective database study which poses its inherent limitations. With the use of any administrative database, the diagnosis of perforation and identification of comorbidity are dependent on the accuracy of coding procedures. However, we would expect the extent of any systematic coding inaccuracies would be similar between the IBD patients and non-IBD controls. The NIS also does not include outpatients or those who died before hospitalization or patients who got the procedure and developed perforation after discharge. Thus there is no longitudinal follow up in the NIS database which could have altered the results. We did not have information on the severity of the disease and exact indications for colonoscopy in these inpatients. Also we could not obtain information on the endoscopists' experience, specialty/credential, the circumstances in which perforations occurred and information on the use of IBD medications. The CCI may also not be enough to capture all the comorbidities of the included patients. 18 Furthermore, perforations that result from incomplete colonoscopies or sigmoidoscopies and colonoscopies billed as sigmoidoscopies would not be included in our study, which would have altered or underestimated the perforation rate. Patients with severe pancolitis although started off as colonoscopy could have had an incomplete colonoscopy or just a sigmoidoscopy and the procedure would have billed as a safe colonoscopy. Thus the question of whether it is safe to perform colonoscopy in patients with severe pancolitis is still unanswered through this study. Also the NIS database cannot be used to assess the temporal relationship of colonoscopy and the perforation. We cannot obtain the time line of the occurrence of perforation using the NIS database. The results of our study are more hypotheses generating than hypothesis testing given these limitations. Nevertheless, to our knowledge, this is the largest study to date on the risk of perforation in hospitalized IBD patients. This dataset is a population-based representation of all hospitalized IBD patients in the US, reflecting all types of hospital settings, insurance payers, and geographic regions. Thus the selected study population enhances the generalizability of our data and minimizes referral bias associated with single-center studies from tertiary medical institutions. Despite its inherent limitations, administrative data from NIS have provided an important means for surveying national wide trends in the risk of colonoscopic perforation among IBD inpatients. This study has a hypothesis highlighted the importance of careful diligence in performing colonoscopy in IBD inpatients. The other limitation of the study is that we do not have data on the indication for inpatient colonoscopy in control patients and also in IBD inpatients other than dilatation and polypectomy.
To conclude, colonoscopy in IBD inpatients appears to be associated with an increased risk of perforation. Those patients at risk for perforation should be monitored closely 
